Viatris Inc (NASDAQ:VTRS)
| 11.68 Delayed Data As of May 19 |  +0.41 / +3.64%Today’s Change | 9.66 Today|||52-Week Range 15.95 | -13.67% Year-to-Date |
VTRS Regular Dividend: VTRS will begin trading ex-dividend on 05/23/22 with a $0.12 dividend payable to shareholders of record as of 05/24/22.
Latest VTRS News | Press Releases
| BERKSHIRE ASSET MANAGEMENT LLC/PA's Top 5 Sells of the 1st Quarter May 18 / GuruFocus News - Paid Partner Content | Why Viatris Stock Is Popping Today May 09 / MotleyFool.com - Paid Partner Content |
| COURAGE CAPITAL MANAGEMENT LLC Buys 1, Sells 4 in 1st Quarter May 18 / GuruFocus News - Paid Partner Content | Viatris' (VTRS) Q1 Earnings Beat, Revenues Miss Estimates May 09 / Zacks.com - Paid Partner Content |
| 2 Stocks That Are Ridiculously Cheap Right Now May 14 / MotleyFool.com - Paid Partner Content | Viatris (VTRS) Q1 Earnings Beat Estimates May 09 / Zacks.com - Paid Partner Content |
| 3 Dirt-Cheap Stocks You Can Buy Right Now May 14 / MotleyFool.com - Paid Partner Content | Theravance's (TBPH) Q1 Earnings and Sales Miss Estimates May 06 / Zacks.com - Paid Partner Content |
| Chris Davis Whittles Down Top Holding Wells Fargo, Adds to Meta Platforms Stake May 13 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 11.27 |
| Today’s open | 11.12 |
| Day’s range | 11.11 - 11.79 |
| Volume | 1,084,821 |
| Average volume (3 months) | 13,332,259 |
| Market cap | $13.4B |
Data as of 4:03pm ET, 05/19/2022
Growth & Valuation
| Earnings growth (last year) | +5.78% |
| Earnings growth (this year) | -55.76% |
| Earnings growth (next 5 years) | +0.13% |
| Revenue growth (last year) | +49.53% |
| P/E ratio | 83.4 |
| Price/Sales | 0.92 |
| Price/Book | 0.65 |
Competitors
| ---- | ||
| ALNYAlnylam Pharmaceutic... | +1.10 | +0.86% |
| INCYIncyte Corp | +0.95 | +1.29% |
| BHVNBiohaven Pharmaceuti... | -0.65 | -0.46% |
Data as of 4:03pm ET, 05/19/2022
Financials
| Next reporting date | August 8, 2022 |
| EPS forecast (this quarter) | $0.83 |
| Annual revenue (last year) | $17.9B |
| Annual profit (last year) | -$1.3B |
| Net profit margin | -7.11% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Canonsburg, Pennsylvania |
Forecasts
